This is the authors' abstract. We don't add key points for this paper.
Printing technologies have opened larger windows of innovation and creativity to biomaterials engineers by providing them with the ability to fabricate complex shapes in a reasonable time, cost, and weight. However, there has always been a trouble with function adjusting in printing technologies in view of the multiplicity of materials and apparatus parameters. 3D printing, also known as additive manufacturing, revolutionized biomaterials engineering by the conversion of a digital subject into a printed object (implants, scaffolds, or diagnostics and drug delivery devices/systems).Inspired by the lessons learned from 3D printing, the concept of 4D printing (better called shape-morphing fabrication) was conceptualized and put into practice to reply on the need for responsiveness of the printed platforms to a stimulus (light, pH, temperature, voltage, humidity, etc.) in a programmable manner. Later, the next milestone in printing technology was reached by 5D printing, by which the desired objects could be printed from five axes compared to the upward one-point printing by 3D printers. 5D printers use ≈20-30% fewer materials comparatively, enabling the printing of curved surfaces. Nevertheless, all bioprinters need a bio-ink with qualified characteristics for the biomedical applications. Thus, we discussed briefly the cell viability, scaffold biomimicry, scaffold biodegradation and affordability.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shokrani et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: